MANOJ KUMAR
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology RIO RANCHO, NM NPI 1104358043
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NM NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$2,310.29
- Category: General Payments
- Program years: PY2020–2024
- Record count: 62
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $799.19 across 41 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $799.19 | 41 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $144.55 | 7 |
| Exelixis Inc. | $54.05 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $53.81 | 3 |
| Celgene Corporation | $51.00 | 2 |
| Karyopharm Therapeutics Inc. | $46.96 | 2 |
| Janssen Biotech, Inc. | $46.84 | 2 |
| E.R. Squibb & Sons, L.L.C. | $45.32 | 3 |
| ABBVIE INC. | $39.61 | 2 |
| Acerta Pharma LLC | $37.31 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $37.25 | 2 |
| ARRAY BIOPHARMA INC | $32.69 | 2 |
| Genmab U.S., Inc. | $30.97 | 2 |
| Daiichi Sankyo Inc. | $28.20 | 1 |
| Genentech USA, Inc. | $27.87 | 1 |
| Incyte Corporation | $21.21 | 1 |
| SOBI, INC | $19.19 | 1 |
| GENZYME CORPORATION | $18.43 | 1 |
| Tempus AI, Inc | $17.79 | 1 |
| Astellas Pharma US Inc | $16.17 | 1 |
| JAZZ PHARMACEUTICALS INC. | $15.04 | 1 |
| Merck Sharp & Dohme Corporation | $14.93 | 1 |
By program year
Records — PY2024 (41)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.